Skip to contentCanute Scott A — LILLY ELI & CO insider: 86 transactions · InsiderLensCanute Scott A
- President, Mfg. Operations at LILLY ELI & CO · on record since Jan 24, 2006
- Executive VP at GENZYME CORP · on record since Mar 17, 2010
- Director at Akebia Therapeutics, Inc. · on record since Aug 2, 2016
- Director at Flexion Therapeutics Inc · on record since Mar 6, 2015
- Director at Protara Therapeutics, Inc. · on record since Jul 23, 2015
- Director at Outlook Therapeutics, Inc. · on record since May 18, 2016
- Director at IMMUNOMEDICS INC · on record since Mar 23, 2017
- Director at Oncorus, Inc. · on record since Dec 16, 2020
Insider trading activity of Canute Scott A
- Transactions on record
- 86
- since Jan 18, 2005
- Open-market buys
- 0
- Open-market sells
- 2
- Companies traded
- 8
- last filing Jun 24, 2022
Figures computed from official regulatory filings — methodology.
Companies where Canute Scott A has traded
- Oncorus, Inc.3 tx · Jun 24, 2022
- Flexion Therapeutics Inc20 tx · $76.5K · Nov 19, 2021
- IMMUNOMEDICS INC12 tx · Oct 23, 2020
- Akebia Therapeutics, Inc.5 tx · Jun 10, 2019
- Protara Therapeutics, Inc.4 tx · Jun 11, 2018
- Outlook Therapeutics, Inc.8 tx · Oct 30, 2017
- GENZYME CORP8 tx · $12M · Apr 6, 2011
- LILLY ELI & CO26 tx · $1.8M · Feb 12, 2007
Track record of Canute Scott A
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Canute Scott A
Co-insiders of Canute Scott A
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Abingworth LLPProtara Therapeutics, Inc.
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 24, 2022 | AwardD | 12,500 | 0.00 USD | $0 | SEC |
| Nov 19, 2021 | OtherD | -12,500 | — | — | SEC |
| Nov 19, 2021 | OtherD | -12,500 | — | — | SEC |
| Nov 19, 2021 | OtherD | -12,500 | — | — | SEC |
| Nov 19, 2021 | OtherD | -18,000 | — | — | SEC |
| Nov 19, 2021 | OtherD | -7,000 | — | — | SEC |
| Nov 19, 2021 | OtherD | -12,500 | — | — | SEC |
| Nov 19, 2021 | Other | -9,000 | 8.50 USD | $76.5K | SEC |
| Nov 19, 2021 | OtherD | -7,000 | — | — | SEC |
| Nov 19, 2021 | OtherD | -9,000 | — | — | SEC |
| Jun 28, 2021 | Award | 4,500 | 0.00 USD | $0 | SEC |
| Jun 28, 2021 | AwardD | 7,000 | 0.00 USD | $0 | SEC |
| Jun 17, 2021 | AwardD | 12,500 | 0.00 USD | $0 | SEC |
| Jun 17, 2021 | AwardD | 25,000 | 0.00 USD | $0 | SEC |
| Oct 23, 2020 | OtherD | -155,286 | — | — | SEC |
| Oct 23, 2020 | Other | -13,516 | — | — | SEC |
| Oct 23, 2020 | OtherD | -3,718 | — | — | SEC |
| Jun 22, 2020 | AwardD | 6,540 | 0.00 USD | $0 | SEC |
| Jun 22, 2020 | Award | 3,718 | 0.00 USD | $0 | SEC |
| Jun 12, 2020 | AwardD | 7,000 | 0.00 USD | $0 | SEC |
| Jun 12, 2020 | Award | 4,500 | 0.00 USD | $0 | SEC |
| Jun 21, 2019 | AwardD | 12,500 | 0.00 USD | $0 | SEC |
| Jun 11, 2019 | AwardD | 17,077 | 0.00 USD | $0 | SEC |
| Jun 11, 2019 | Award | 9,667 | 0.00 USD | $0 | SEC |
| Jun 10, 2019 | AwardD | 20,100 | 0.00 USD | $0 | SEC |